19/05/26
Clinical trials are under unprecedented pressure to move fast. Patient recruitment alone creates a ticking clock - once participants are enrolled, every hour counts. Any delay in recruitment doesn’t just push timelines back; it accelerates cost escalation and jeopardizes patient engagement.
What often gets overlooked and is a hidden contributor to post‑recruitment delays is not in the protocol, the site, or the supply chain but in the primary packaging.
Once a cohort is recruited, trial teams must move rapidly to dosing. Any delay in delivering packaged, blinded, and compliant investigational product can:
This is where the choice of primary packaging partner becomes pivotal.
Clinical supply chains are fragile and packaging bottlenecks often create the first cracks.
A reliable primary packaging partner helps with:
A provider equipped to move quickly and consistently, keeps trials on schedule even as conditions shift.
Adelphi’s global partner network is engineered for speed. With broad access to stocked and specialist components, helping sponsors bypass procurement delays that often occur with niche or customized primary packaging.
This network enables faster sourcing of specialist pharmaceutical containers, supported by a stable and reliable supply chain. It allows for rapid turnaround times to meet urgent project timelines, while also providing the flexibility to support both early-phase development and larger-scale clinical supply requirements, ultimately minimizing risk during the most time-critical moments of a study.
Every trial is unique. Dose formats, blinding requirements, container interactions, as well as handling protocols that vary widely.
A capable packaging partner can tailor:
This flexibility allows sponsors to match packaging precisely to protocol mechanics, improving compliance and usability at the site level.
Differences between active drugs and placebos, even subtle ones like color, viscosity, or opacity-can compromise trial integrity and lead to delays if not addressed before dosing. Adelphi’s blinding and masking solutions address this without slowing the study, using opaque or tinted sleeves, bespoke covers, and container masking solutions to eliminate visible distinctions. In cases where devices or delivery systems differ in appearance, preformed sleeves can standardize the look and feel, maintaining the blind without the need for costly redesign of the drug delivery device itself.
In a world where patient recruitment drives urgency and delays are increasingly costly, primary packaging is a strategic asset - not a commodity. Partnering with the right provider ensures:
For sponsors under pressure, Adelphi’s speed, network strength, and tailored solutions help keep trials moving from recruitment to dosing-without costly interruptions.
Primary packaging plays a critical role in maintaining trial timelines, product integrity, and patient safety. Delays in sourcing or preparing compliant packaging can impact recruitment schedules, dosing timelines, and overall study efficiency.
Inquire todayPackaging delays can lead to postponed dosing, protocol disruptions, re-screening of patients, increased operational costs, and reduced patient retention. In time-sensitive studies, these delays may significantly impact trial progress.
Inquire todayBlinding is the process of preventing participants and researchers from knowing which treatment a patient receives. This helps reduce bias and maintain the integrity and reliability of clinical trial results.
View product